State of the art in hormonal contraception: An overview

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 4 SUPPL., 2004, Pages

  Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Contraceptive steroids; Injectable implantable delivery systems; Oral contraceptives

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL CIPIONATE; ESTROGEN; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORELGESTROMIN; STEROID;

ACNE; ADENOCARCINOMA; ARTERY THROMBOSIS; BIRTH CONTROL; BLEEDING; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLORECTAL CANCER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM CANCER; FEMALE; HEART INFARCTION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LUNG EMBOLISM; OVARY CANCER; OVARY CYST; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; UTERINE CERVIX CARCINOMA; UTERUS BLEEDING; VAGINA RING; VEIN THROMBOSIS;

EID: 2342428330     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.01.058     Document Type: Article

References (18)

1. Mishell DR. Prevention of unplanned pregnancies in U.S. women. J Reprod Med 2000;45:867-71.
2. Alan Guttmacher Institute. Sharing responsibility: women, society, abortion worldwide. New York: AGI; 1999. p. 28.
3. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-29, 46.
4. Westoff CH, Ryder NB. National Fertility Study, 1965. DAAPP Data Set No. 48-49. Available at: http://www.sscnet-ucla.edu/lsst/da/index/techinfo/m0091. htm.
5. Westoff CH, Ryder NB. National Fertility Study, 1970. DAAPP Data Set No. 50-51. Available at: http://www.socio.com/srch/summary/daappp/dap50-51.htm.
6. National Center for Health Statistics. National Survey of Family Growth, 1973. Hyattsville (MD): US Dept of Health and Human Services, Division of Data Services; 1973.
7. National Center for Health Statistics. National Survey of Family Growth, 1976. Hyattsville (MD): US Dept of Health and Human Services, Division of Data Services; 1976.
8. National Center for Health Statistics. National Survey of Family Growth, 1982. Hyattsville (MD): US Dept of Health and Human Services, Division of Data Services; 1982.
9. National Center for Health Statistics. National Survey of Family Growth, 1988. Hyattsville (MD): US Dept of Health and Human Services, Division of Data Services; 1988.
10. National Center for Health Statistics. National Survey of Family Growth, 1995. Hyattsville (MD): US Dept of Health and Human Services, Division of Data Services; 1995.
11. Woods JW. Oral contraceptives and hypertension. Lancet 1967;2:653.
12. Okawara SH, Calkins RA. Cerebral arterial occlusive disease with telectangiectasia associated with oral contraceptives. Arch Neurol 1973;29:60-2.
13. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973;2:926-9.
14. Ayre JE, Hillemans HG, LeGuerrier J, Arsenault J. Influence of norethynodrel and mestranol upon cervical dysplasia and carcinoma in situ. Obstet Gynecol 1966;28:90-8.
15. Sichuk G, Fortner JG, Der BK. Evaluation of the influence of norethynodrel with mestranol (Enovid) in middle-aged male Syrian (golden) hamsters, with particular reference to spontaneous tumours. Acta Endocrinol (Copenh) 1967;55:97-107.
16. Mishell DR Jr. Oral contraception: past, present, and future perspectives. Int J Fertil 1991;36(Suppl 1):7-18.
17. Pratt WF, Bachrach CA. What do women use when they stop using the pill? Fam Plann Perspect 1987;19:257-66.
18. Mishell DR Jr. The pharmacologic and metabolic effects of oral contraceptives. Int J Fertil 1989;34(Suppl):21-6.